#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Polyneuropathy Skin cancer Peripheral T-cell lymphoma unspecified Angelman's syndrome Wiskott-Aldrich syndrome Chorioretinitis Alveolar rhabdomyosarcoma Obesity Desmoplastic small round cell tumour Tourette's disorder Systemic candida Human papilloma virus immunisation Li-Fraumeni syndrome Ovarian cancer stage III Alagille syndrome More trials…

    Learn about Rare Diseases

    Basal cell naevus syndrome – Basic Information Lennox-Gastaut syndrome – Diagnostics Propionic acidaemia Richter’s syndrome Turner’s syndrome – Life with Disease Cystic fibrosis – Diagnostics Behcet’s syndrome – Treatment Sjogren’s syndrome – Life with Disease Ornithine transcarbamoylase deficiency – Trials in Disease Methylmalonic acidaemia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzyl Alcohol Mps-214 Mk-1088 Dactinomycin Glucose Monohydrate Pirtobrutinib Hypothalamic Phospholipids Mps-200 HSP-CAR19M RUBIDIUM CHLORIDE Ubamatamab Parsaclisib Hydrochloride Atacicept Allopurinol Sodium Molidustat Sodium Norfloxacin Captopril Lumasiran SC0062 Camonsertib More therapies…

    Learn about Your Condition

    Neoplasm Post-traumatic headache Plasma cell myeloma refractory Cholestatic pruritus Lymphoma Rectal cancer stage III Placenta praevia Vascular calcification Post-traumatic stress disorder Generalised anxiety disorder Hereditary ataxia Cold urticaria Oesophageal atresia Colorectal cancer stage II Arterial stiffness More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Sevuparin for Patients with Chronic Kidney Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • SEVUPARIN
    Italy

  • Study on Fecal Microbiota Transplantation for Crohn’s Disease Patients in Remission After Stopping Anti-TNF Therapy

    Recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    • Placebo
    France

  • Study on Pneumococcal Vaccine Response in Healthy Volunteers Using Pneumococcal Polysaccharide Conjugate Vaccine and Drug Combination

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 3 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    The Netherlands

  • Study on Antibody Responses in Healthy Individuals After Intranasal and Intramuscular Influenza Vaccination with Fluenz Tetra and Vaxigrip Tetra

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • A/DARWIN/9/2021 (H3N2) – LIKE STRAIN (A/NORWAY/16606/2021, MEDI 355293)
    • Influenza Virus A/California/122/2022 San-022 (H3N2) Strain (Split, Inactivated)
    • INFLUENZA VIRUS B/AUSTRIA/1359417/2021 – LIKE STRAIN (B/AUSTRIA/1359417/2021, MEDI 355292)
    The Netherlands

  • Study on the Safety of PD L 506 for Patients with First-Time Colorectal Cancer and Healthy Individuals

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Aminolevulinic Acid Hydrochloride
    Germany

  • Study of Different Doses of MVA-BN Vaccine Booster for Adults with Mpox: Comparing Standard and Reduced Doses

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Monkeypox
    Investigated Drugs:
    • Modified Vaccinia Ankara – Bavarian Nordic Live Virus
    The Netherlands
Previous Page
1 … 194 195 196 197 198 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!